TIAA CREF INVESTMENT MANAGEMENT LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 78 filers reported holding OCULAR THERAPEUTIX INC in Q4 2016. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q1 2019$236,000
-26.2%
59,473
-26.0%
0.00%
Q4 2018$320,000
-60.9%
80,403
-32.4%
0.00%
Q3 2018$818,000
+95.7%
118,946
+92.0%
0.00%
Q2 2018$418,000
-9.7%
61,943
-12.9%
0.00%
Q1 2018$463,000
+98.7%
71,087
+35.8%
0.00%
Q4 2017$233,000
-32.3%
52,351
-6.0%
0.00%
Q3 2017$344,000
-66.6%
55,719
-49.8%
0.00%
-100.0%
Q2 2017$1,029,000
+0.6%
111,019
+0.7%
0.00%0.0%
Q1 2017$1,023,000
+61.4%
110,234
+45.5%
0.00%
Q4 2016$634,000
+19.8%
75,785
-1.5%
0.00%
Q3 2016$529,000
+38.8%
76,9350.0%0.00%
Q2 2016$381,000
-18.6%
76,935
+58.7%
0.00%
Q1 2016$468,000
+3.1%
48,4680.0%0.00%
Q4 2015$454,000
-44.3%
48,468
-16.4%
0.00%
-100.0%
Q3 2015$815,000
-25.6%
57,972
+11.3%
0.00%0.0%
Q2 2015$1,096,000
+17.7%
52,093
+134.8%
0.00%0.0%
Q1 2015$931,000
+229.0%
22,183
+84.4%
0.00%
Q4 2014$283,000
+79.1%
12,029
+14.1%
0.00%
Q3 2014$158,00010,5390.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q4 2016
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$19,223100.00%
Opaleye Management Inc. 6,468,000$20,309,5206.61%
DELTEC ASSET MANAGEMENT LLC 2,061,797$6,474,0431.48%
Endurant Capital Management LP 353,707$1,110,6401.00%
SECTORAL ASSET MANAGEMENT INC 969,350$3,043,7590.59%
NOTTINGHAM ADVISORS, INC. 194,266$609,9950.09%
Covestor Ltd 37,404$1170.09%
GSA CAPITAL PARTNERS LLP 233,582$7330.06%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 342,111$1,074,2290.03%
Polar Asset Management Partners Inc. 263,763$828,2160.02%
View complete list of OCULAR THERAPEUTIX INC shareholders